3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Colorectal Neoplasms
4
Stomach Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma Of Esophagus
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Meningeal Neoplasms
1
HER2-positive Breast Cancer
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Cholangiocarcinoma
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Paclitaxel
9
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
pembrolizumab
7
Albumin-Bound Paclitaxel
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Nivolumab
5
Irinotecan
5
Docetaxel
5
Pemetrexed
4
Everolimus
4
Erlotinib Hydrochloride
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
trifluridine tipiracil drug combination
2
regorafenib
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
tucatinib
×
Clear all
No trials found.